Society for Immunotherapy of Cancer (SITC) shared a post on LinkedIn:
“During Cancer Immunotherapy Month™, the Society for Immunotherapy of Cancer (SITC) celebrates the next generation of trainees and early‑career individuals who will pioneer life‑saving immunotherapies for cancer patients across the globe.
As part of this commitment, the SITC Forward Fund supports the full trajectory of early‑career professionals – from career development and research support to networking opportunities and increased visibility.
Your generous support of the Forward Fund allows SITC to provide valuable support through travel awards for early‑career individuals to attend educational and networking events that provide a platform to highlight their research. At SITC 2026, we will recognize 41 Early Career Investigator Awards plus dozens more travel awards throughout the year.
Since 2012, the SITC Forward Fund awarded more than $6 million to early career scientists. Your contributions make this all possible!
Help create more opportunities for the next wave of leaders in immuno-oncology by donating today.”
Other articles about Immunotherapy on OncoDaily.